Avidity Partners Management LP Sells 8,400 Shares of HealthEquity, Inc. $HQY

Avidity Partners Management LP cut its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 33.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,900 shares of the company’s stock after selling 8,400 shares during the period. Avidity Partners Management LP’s holdings in HealthEquity were worth $1,548,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in HQY. William Blair Investment Management LLC bought a new position in HealthEquity in the fourth quarter worth approximately $169,956,000. Norges Bank bought a new position in HealthEquity in the fourth quarter worth approximately $66,927,000. AQR Capital Management LLC raised its position in HealthEquity by 148.5% in the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after acquiring an additional 661,795 shares during the period. Northwestern Mutual Wealth Management Co. raised its position in HealthEquity by 229,985.6% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 478,578 shares of the company’s stock worth $43,843,000 after acquiring an additional 478,370 shares during the period. Finally, Westfield Capital Management Co. LP raised its position in HealthEquity by 35.7% in the third quarter. Westfield Capital Management Co. LP now owns 1,716,658 shares of the company’s stock worth $162,688,000 after acquiring an additional 451,450 shares during the period. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Stock Down 0.7%

Shares of HQY stock opened at $88.34 on Friday. The company has a market capitalization of $7.39 billion, a price-to-earnings ratio of 33.09, a PEG ratio of 1.49 and a beta of 0.21. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $106.60. The company’s fifty day moving average price is $84.64 and its 200-day moving average price is $85.87. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. The company’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Sell-side analysts expect that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have weighed in on HQY. Weiss Ratings upgraded shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. Raymond James Financial set a $100.00 price objective on shares of HealthEquity in a research report on Tuesday, February 17th. Citigroup restated a “market outperform” rating on shares of HealthEquity in a research report on Monday, June 1st. JPMorgan Chase & Co. decreased their price objective on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 18th. Finally, Jefferies Financial Group set a $108.00 price objective on shares of HealthEquity in a research report on Thursday, February 19th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $110.57.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. Following the sale, the executive vice president directly owned 91,141 shares in the company, valued at approximately $8,202,690. The trade was a 7.60% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the completion of the sale, the director owned 19,733 shares in the company, valued at approximately $1,775,970. This represents a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 13,081 shares of company stock worth $1,193,000. Insiders own 1.60% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.